Drug Trial Radar · NCT00807326
A Comparison of Three Medications to Treat Diarrhea in Adults.
Last checked: Nov 19, 2026Latest source record: Jul 10, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
415
Actual
Start
Nov 2008
Primary completion
Aug 2009
Study completion Nov 2009
Sponsor
- Lead sponsor
- McNeil ABIndustry
- Sponsor type
- Industry
- First posted
- Dec 11, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A comparison of three medications to treat diarrhea in adults.
Conditions
- Diarrhea
Interventions
Loperamide/simeticone 2 mg/125 mg capletsDrug
Oral, 2 caplets taken initially at investigator site followed by one caplet after each unformed stool, maximum 4 caplets in a 24 hour period for a maximum of 48 hours (per product label)
Loperamide/simeticone 2 mg/125 mg chewable tabletsDrug
Oral, 2 chewable tablets taken initially at the site followed by one chewable tablet after each unformed stool, maximum 4 chewable tablets in a 24 hour period for a maximum of 48 hours (per product label)
Probiotic Saccharomyces boulardii 250 mg capsulesDrug
Oral, 1 capsule twice a day, maximum 2 capsules in a 24 hour period for a maximum of 5 days (per product label)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of unformed stoolsTime frame: 0-24 hours
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Manipal Goa Hospital
Mormugao, Goa, India
Vrundavan Hospital & Research Centre
Mormugao, Goa, India
North West Medical
San José del Cabo, Baja California Sur, Mexico
Dr. Maxwell´s Clinic
San Miguel de Allende, Guanuajuato, Mexico
Hospital Amerimed Puerto Vallarta
Puerto Vallarta, Jalisco, Mexico
Servicios Medicos de la Bahia
Puerto Vallarta, Jalisco, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.